Pulmonary Pharmacology and Therapeutics : Impact Factor & More
eISSN: 1522-9629pISSN: 1094-5539
Share this on:
Aims and Scope of Pulmonary Pharmacology and Therapeutics
Pulmonary Pharmacology & Therapeutics is a medical journal published by Elsevier that covers research on the pharmacotherapy of lung diseases. It was established in 1988 as Pulmonary Pharmacology and obtained its current title in 1997. Less
Key Metrics
CiteScore 
5.8
H-Index
78
Impact Factor
< 5
SJR
Q2Biochemistry (medical)
SNIP
0.84
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Pulmonary Pharmacology and Therapeutics
Pulmonary Pharmacology and Therapeutics Journal Specifications
| Overview | |
| Publisher | ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 1988 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Pulmonary Pharmacology and Therapeutics ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Pulmonary Pharmacology and Therapeutics
Effectiveness of Mepolizumab and Dupilumab in Patients with Asthma-COPD Overlap (ACO) compared to Severe Uncontrolled Asthma: A Retrospective Observational Cohort Study.
- 1 Mar 2026
- Pulmonary pharmacology & therapeutics
Echocardiographic effects of dupilumab in patients with severe type 2 asthma.
- 1 Mar 2026
- Pulmonary pharmacology & therapeutics
Targeting ELK-1 transcription factor and mechanosensitive MDM4 receptor using an HCN channel blocker alleviates lung fibrosis.
- 1 Jan 2026
- Pulmonary pharmacology & therapeutics
Setting expectations with oral selexipag: an expert consensus-based approach on best practices to initiate, dose, titrate, and manage side effects (SEs) in patients with pulmonary arterial hypertension (PAH).
- 1 Jan 2026
- Pulmonary pharmacology & therapeutics
Artificial Intelligence in the Development of Rentosertib: A Novel TNIK Inhibitor for Idiopathic Pulmonary Fibrosis - A Letter to Editor.
- 30 Dec 2025
- Pulmonary pharmacology & therapeutics
Effectiveness of Mepolizumab and Dupilumab in Patients with Asthma-COPD Overlap (ACO) compared to Severe Uncontrolled Asthma: A Retrospective Observational Cohort Study.
- 1 Mar 2026
- Pulmonary pharmacology & therapeutics
Echocardiographic effects of dupilumab in patients with severe type 2 asthma.
- 1 Mar 2026
- Pulmonary pharmacology & therapeutics
Targeting ELK-1 transcription factor and mechanosensitive MDM4 receptor using an HCN channel blocker alleviates lung fibrosis.
- 1 Jan 2026
- Pulmonary pharmacology & therapeutics
Setting expectations with oral selexipag: an expert consensus-based approach on best practices to initiate, dose, titrate, and manage side effects (SEs) in patients with pulmonary arterial hypertension (PAH).
- 1 Jan 2026
- Pulmonary pharmacology & therapeutics
Artificial Intelligence in the Development of Rentosertib: A Novel TNIK Inhibitor for Idiopathic Pulmonary Fibrosis - A Letter to Editor.
- 30 Dec 2025
- Pulmonary pharmacology & therapeutics
FAQs on Pulmonary Pharmacology and Therapeutics
How long has Pulmonary Pharmacology and Therapeutics been actively publishing? 
What is the publishing frequency of Pulmonary Pharmacology and Therapeutics?
How many articles did Pulmonary Pharmacology and Therapeutics publish last year?
What is the eISSN & pISSN for Pulmonary Pharmacology and Therapeutics?
What is Citescore for Pulmonary Pharmacology and Therapeutics?
What is the H Index for Pulmonary Pharmacology and Therapeutics ?
What is SNIP score for Pulmonary Pharmacology and Therapeutics?
What is the SJR for Pulmonary Pharmacology and Therapeutics?
Who is the publisher of Pulmonary Pharmacology and Therapeutics?
